Neurotechnology offers new solutions to treating brain diseases (Dell Tech Culture):
“A new wave of medical technologies is changing the way we approach studying the brain and treating patients suffering from neurological diseases and mental illness.
For people suffering from Parkinson’s, epilepsy, OCD and severe depression, these technological advancements are parting the sea of neuropharmacology by offering targeted, noninvasive alternatives to pills.
“Drugs flatten your whole body,” said Thomas Knöpfel, chair of optogenetics and circuit neuroscience at Imperial College of London. “You want to treat an organ, like the brain, but you also end up with receptors on your kidneys and liver, and a lot of side effects…”
Both DBS (Deep Brain Stimulation) and optogenetics are far from perfect technologies, but they are notable because their method of brain activation presents an alternative to drug-centric treatment plans.”